Smallwood Wealth Investment Management’s LAVA Therapeutics LVTX Stock Holding History

Smallwood Wealth Investment Management’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26	Closed	-$40	–	531
2025 Q3	$40	Buy	+26	New	+$39	﹤0.01%	510

Smallwood Wealth Investment Management's LVTX Position: Q4 2025 in Review

Smallwood Wealth Investment Management sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 26 shares — an estimated $40 sold.

Smallwood Wealth Investment Management first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $40 in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

Smallwood Wealth Investment Management reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
Smallwood Wealth Investment Management sold 26 LAVA Therapeutics shares in Q4 2025, an estimated $40.
Smallwood Wealth Investment Management first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
Smallwood Wealth Investment Management's LAVA Therapeutics position peaked at $40 in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on Smallwood Wealth Investment Management's 13F filing for Q4 2025, filed 23 Jan 2026.